Related Experiment Video
Updated: Feb 28, 2026
Murine Corneal Transplantation: A Model to Study the Most Common Form of Solid Organ Transplantation
Published on: November 17, 2014
Probable Donor-Derived Cytomegalovirus Disease After Keratolimbal Allograft Transplantation
Albert Y Cheung1, Amit Govil, Scott R Friedstrom
1*Cincinnati Eye Institute, Cincinnati, OH; †Department of Ophthalmology, University of Cincinnati, Cincinnati, OH; ‡Division of Nephrology and Hypertension, University of Cincinnati, Cincinnati, OH; and §Division of Infectious Diseases, TriHealth, Cincinnati, OH.
Purpose:
To report a case of probable donor-derived cytomegalovirus (CMV) infection after keratolimbal allograft (KLAL) transplantation.
Methods:
Observational case report.
Results:
A 41-year-old man with a history of aniridic keratopathy and limbal stem cell deficiency underwent KLAL in his right eye. Preoperatively, he was negative for CMV IgG and IgM. Postoperatively, he was maintained on tacrolimus and mycophenolate mofetil for systemic immunosuppression; he was also on prophylactic valganciclovir (for CMV) and trimethoprim/sulfamethoxazole (for pneumocystis pneumonia) for 1 month. Approximately 5 weeks postoperatively, he developed a nonproductive cough, rhinorrhea, and dyspnea. His condition did not improve with oral azithromycin or levofloxacin. He developed worsening symptoms over the next 2 weeks despite therapy. The serum CMV polymerase chain reaction was positive, and he was readministered valganciclovir with subsequent resolution of symptoms.
Conclusions:
We present the first case of CMV disease in a seronegative patient who received a presumed CMV-seropositive donor KLAL. Similar to solid organ transplantation, prophylactic and therapeutic management of CMV infection is necessary in the setting of systemic immunosuppression.
